Skip to main content
SpringerLink
Log in

Pharmacotherapy in Common Allergic Diseases

  • Chapter
Multidisciplinary Approaches to Allergies

Part of the book series: Advanced Topics in Science and Technology in China ((ATSTC))

  • 1686 Accesses

Abstract

Allergic diseases are immunologically mediated hypersensitivity reactions that are increasing in prevalence throughout the world. Symptoms associated with allergic diseases can significantly affect one’s sense of well-being. Management of allergic diseases involves diagnostic testing to identify suspected allergens accompanied by subsequent avoidance measures and pharmacotherapy. Pharmacotherapy plays an important role in the control and alleviation of allergic symptoms, but does not cure the underlying allergy. Nevertheless, the use of medications in allergy treatment is an essential component of effective management of allergic disease and can greatly enhance one’s quality of life (WHO et al., 2002). A wide array of medications is available for the treatment of common allergic diseases such as allergic rhinitis, allergic conjunctivitis, and asthma. Classes of medications recom- mended for use in allergic diseases are reviewed, and include antihistamines, leukotriene antagonists, mast cell stabilizers, corticosteroids, anticholinergics, and beta-agonists. Specific indications, mechanism of action, and potential side effects of these medications are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Adkinson, N.F., Busse, W., Bochner, B., et al. (2008). Middleton’s Allergy: Principles and Practice (7th ed.). Mosby: Elsevier, pp. 1575–1583.

    Google Scholar 

  • Bachert, C., van Cauwenberge, P. (2003). The WHO ARIA (allergic rhinitis and its impact on asthma) initiative. Chem Immunol Allergy, 82, 119–126.

    Article  PubMed  CAS  Google Scholar 

  • Barnes, P.J. (1998). Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol, 102, 531–538.

    Article  PubMed  CAS  Google Scholar 

  • Barnes, P.J. (2000). Anti-IgE therapy in asthma: Rationale and therapeutic potential. Int Arch Allergy Immunol, 123, 196–204.

    Article  PubMed  CAS  Google Scholar 

  • Barnes, P.J. (2009). Anti-IgE therapy. Up to date. http://www.uptodate.com/patients/content/.

    Google Scholar 

  • Barney, N.P., Graziano, F.M., Cook, E.B., et al. (2008). Treatment of allergic conjunctivitis. In: Adkinson: Middleton’s Allergy: Principles and Practice (7th ed.). Mosby: Elsevier, p.64.

    Google Scholar 

  • Berger, W., Hampel Jr., F., Bernstein, J., et al. (2006). Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 97(3), 375–381.

    Article  PubMed  CAS  Google Scholar 

  • Berger, W., De Chandt, M.T., Cairns, C.B. (2007). Zileuton: Clinical implications of 5-Lipoxygenase inhibition in severe airway disease. Int J Clin Pract, 61(4), 663–676.

    Article  PubMed  CAS  Google Scholar 

  • Bergeron, C., Boulet, L.P. (2006). Structural changes in airway diseases: Characteristics, mechanisms, consequences, and pharmacologic modulation. Chest, 129, 1068–1087.

    Article  PubMed  CAS  Google Scholar 

  • Berkowitz, R.B., McCafferty, F., Lutz, C., et al. (2006). Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: A pooled analysis of two single-dose, randomized, double-blind, placeboControlled allergen exposure unit studies. Clin Therapy, 28(10), 1658–1669.

    Article  CAS  Google Scholar 

  • Bielory, L., Friedlaender, M.H. (2008). Allergic conjunctivitis. Immunology and Allergy Clinics of North America, 28(1), 43–58.

    Article  PubMed  Google Scholar 

  • Blaiss, M.S. (2007). Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc, 28(2), 145–152.

    Article  PubMed  CAS  Google Scholar 

  • Borish, L.J. (2003). Allergic rhinitis: Systemic inflammation and implications for management. J Allergy Clin Immunol, 112(6), 1021–1031.

    Article  PubMed  CAS  Google Scholar 

  • Boulet, L.P. (2008). Approach to adults with asthma. In: Adkinson: Middleton’s Allergy: Principles and Practice (7th ed.). Mosby: Elsevier, p. 76.

    Google Scholar 

  • Boushey Jr., H.A., Corry, D.B., Fahy, J.V., et al. (2005). In: Mason: Murray & Nadel’s Textbook of Respiratory Medicine (4th ed.). Philadelphia: Elsevier, p. 37.

    Google Scholar 

  • Bousquet, J., Khaltaev, N. (2001). ARIA Workshop Group, World Health Organization: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol, 108(Suppl 5), S147–S334.

    Article  PubMed  CAS  Google Scholar 

  • Bousquet, J., Clark, T. J. H., Hurd, S. et al. (2007). GINA guidelines on asthma and beyond. Allergy, 62, 102–112.

    PubMed  CAS  Google Scholar 

  • Bronsky, E., Boggs, P., Findlay, S., et al. (1995). Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol, 96(2), 139–147.

    Article  PubMed  CAS  Google Scholar 

  • Childhood Asthma Management Program (CAMP) Research Group (2000). Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med., 343(15), 1054–1063.

    Article  Google Scholar 

  • Corren, J., Casale, T., Deniz, Y., et al. (2003). Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. J Allergy Clin Immunol, 111, 87–90.

    Article  PubMed  CAS  Google Scholar 

  • Dana, M.R. (2009). Allergic conjunctivitis. www.uptodate.com.

    Google Scholar 

  • Deschenes, J., Discepola, M., Abelson, M.B. (1999). Comparative evaluation of olopatadine ophthalmic solution (0.1%) using the provocative antigen challenge model. Acta Ophthalmol Scand, 77, 47–52.

    Google Scholar 

  • deShazo, R.D., Kemp, S.F., Corren, J., Feldweg, A.M. (2010). Pharmacotherapy of allergic rhinitis. Up to Date. 2010 (18.1) February (cited 2010 February 10). http://www.uptodate.com/.

    Google Scholar 

  • Devillier, P., Baccard, N., Advenier, C. (1999). Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I. Synthesis, receptors and role of leukotrienes in asthma. Pharmacol Res, 40, 3–13.

    Article  PubMed  CAS  Google Scholar 

  • Doshnik, P.C., Ehlers, W.H. (1994). Clinical immunologic diseases: Ocular allergy. In: The cornea: Scientific foundation and clinical practice (3rd ed.). Boston: Little Brown.

    Google Scholar 

  • Ducharme, F.M. (2003). Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: Systematic review of current evidence. BMJ, 326, 621.

    Article  PubMed  CAS  Google Scholar 

  • Dykewicz, M.S., Fineman, S., Skoner, D.P., et al. (1998). Diagnosis and management of rhinitis: Complete guidelines of the joint task force on practice parameters in allergy, asthma and immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol, 81(5 Pt 2), 478–518.

    Article  PubMed  CAS  Google Scholar 

  • Eickelberg, O., Pansky, A., Mussmann, R., et al. (1999). Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem, 274, 12933–12938.

    Article  PubMed  CAS  Google Scholar 

  • Evans, D.J., Taylor, D.A., Zetterstrom, O., et al. (1997). A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med, 337(20), 1412–1418.

    Article  PubMed  CAS  Google Scholar 

  • Guevara, J., Ducharme, F., Keren, R., et al. (2006). Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2009, Issue 3 http://www.thecochranelibrary.com.

    Google Scholar 

  • Guilbert, T.W., Martinez, F.D., Zeiger R.S., et al. (2006). Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med, 354(19), 1985–1997.

    Article  PubMed  CAS  Google Scholar 

  • Hendeles, L., Weinberger, M. (2009). Theophylline use in asthma. http:// www.uptodate.com/ contents/theophylline-use-in-asthma.

    Google Scholar 

  • Juniper, E.F., Stahl, E., Doty, R.L., et al. (2005). Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol, 115(3 Pt 2), S390–413.

    Article  PubMed  Google Scholar 

  • Kemp, J.P. (2009). The use of chromones (cromoglycates) in the treatment of asthma. http://www.uptodate.com/contents/the-use-of-chromones-cromoglycatesin-the-treatment-of-asthma.

    Google Scholar 

  • Kidney, J., Dominguez, M., Taylor, P.M., et al. (1995). Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med, 151(6), 1907–1914.

    Article  PubMed  CAS  Google Scholar 

  • LaForce, C. (1999). Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol, 103(3 Pt 2), S388–S394.

    Article  PubMed  CAS  Google Scholar 

  • Leone, F.T., Fish, J.E., Szefler, S.J., West, S.L. (2003). Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest, 124(6), 2329–2340.

    Article  PubMed  Google Scholar 

  • Manzouri, B., Flynn, T.H., Larkin, F., et al. (2006). Pharma-cotherapy allergic eye disease. Expert Opinion on Pharmacotherapy, 7, 1191–1200.

    Article  PubMed  CAS  Google Scholar 

  • Milgrom, H., Fick Jr., R.B., Su, J.Q., et al. (1999). Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med, 341, 1966–1973.

    Article  PubMed  CAS  Google Scholar 

  • National Asthma Education and Prevention Program Science Base Committee and Expert Panel on the Management of Asthma (2002). Appendix A-2. Usual dosages for asthma medications. J Allergy Clin Immunol, 110(5, Suppl 1), S212–S219, doi: 10.1016/S0091-6749(02)80013-6.

    Google Scholar 

  • National Heart, Lung, and Blood Institute (NHLBI)/World Health Organizatiom (WHO) (1995). Global Initiative for Asthma Management and Prevention. Workshop Report, US Department of Health and Human Services. National Institutes of Health, Bethesda, MD. Pub #95-3659.

    Google Scholar 

  • National Heart, Lung, and Blood Institute (NHLBI) (2007). National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD., 74, 305.

    Google Scholar 

  • Nayak, A., Langdon, R.B. (2007). Montelukast in the treatment of allergic rhinitis: An evidence-based review. Drugs, 67(6), 887–901.

    Article  PubMed  CAS  Google Scholar 

  • Ousler, G.W., Workman, D.A., Torkildsen, G.L. (2007). An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. Clin Ther, 29(4), 611–616.

    Article  PubMed  CAS  Google Scholar 

  • Peters, S., McCallister, J.W., Pascual, R. (2009). Treatment of moderate persistent asthma in adolescents and adults. http://www.uptodate.com/contents/treatment-of-moderate-persistent-asthma-in-adolescents-and-adults.

    Google Scholar 

  • Philip, G., Nayak, A.S., Berger, W.E., et al. (2004). The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin, 20, 1549–1558.

    Article  PubMed  CAS  Google Scholar 

  • Pullerits, T., Praks, L., Ristioja, V., et al. (2002). Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol, 109(6), 949–955.

    Article  PubMed  CAS  Google Scholar 

  • Ratner, P.H., Howland, W.C., Arastu, R., et al. (2003). Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol, 90(5), 536–542.

    Article  PubMed  CAS  Google Scholar 

  • Rivington, R.N., Boulet, L.P., Cote, J., et al. (1995). Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med, 151(2 Pt 1), 325–332.

    Article  PubMed  CAS  Google Scholar 

  • Schultz, B.L. (2006). Pharmacology of ocular allergy. Cur Opinion Allergy Clin Immunol, 6(5), 383–389.

    Article  CAS  Google Scholar 

  • Soler, M., Matz, J., Townley, R., et al. (2001). The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J, 18, 254–261.

    Article  PubMed  CAS  Google Scholar 

  • van Bavel, J., Findlay, S.R., Hampel F.C., Jr., et al. (1994). Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med, 154(23), 2699–2704.

    Article  PubMed  Google Scholar 

  • Vaquerizo, M.J., Casan, P., Castillo, J., et al. (2003). Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax, 58(3), 204–210.

    Article  PubMed  CAS  Google Scholar 

  • Verster, J.C., Volkerts, E.R. (2004). Antihistamines and driving ability: Evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol, 92(3), 294–303; quiz 303-305, 355.

    Article  PubMed  CAS  Google Scholar 

  • Welsh, P.W., Stricker, W.E., Chu, C.P., et al. (1987). Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc, 62(2), 125–134.

    Article  PubMed  CAS  Google Scholar 

  • Wenzel, S. (2009). Treatment of severe asthma in adolescents and adults. http://www.uptodate.com/contents/treatment-of-severe-asthma-in-adolescentsand-adults.

    Google Scholar 

  • Wilson, A.M., O’Byrne, P.M. (2004). Parameswaran KLeukotriene receptor antagonists for allergic rhinitis: A systematic review and meta-analysis. Am J Med, 116 (5), 338–344.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA

    Erina M. Lin

Authors
  1. Erina M. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Zhejiang University Press, Hangzhou and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lin, E.M. (2012). Pharmacotherapy in Common Allergic Diseases. In: Multidisciplinary Approaches to Allergies. Advanced Topics in Science and Technology in China. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31609-8_14

Download citation

Publish with us

Policies and ethics

Search

Navigation